Weight-loss drug semaglutide shows promise in reducing alcohol consumption
The Guardian - 12-Feb-2025Early clinical trial finds the medication curbs cravings and cuts heavy drinking
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Assistant Professor of Medicine at University of North Carolina at Chapel Hill
Dr. Klara Klein, MD, PhD, is an Assistant Professor of Medicine at the University of North Carolina School of Medicine. An endocrinologist and researcher, she focuses on metabolic disorders, obesity, and the effects of weight-loss medications like semaglutide. With expertise in both clinical and translational research, she explores how metabolic treatments can impact broader health issues, including alcohol use disorder.
Visit website: https://www.med.unc.edu/medicine/endocrinology-metabolism/people/klara-klein-md-phd/
See alsoDetails last updated 13-Feb-2025
Early clinical trial finds the medication curbs cravings and cuts heavy drinking